Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Adopting Flexible Strategies to Combat Capacity Shortages

March 06, 2025

More and more contract manufacturers have been looking not at what the state of the supply chain is right now, but what it may be in the next three to five years.

CordenPharma Selects Switzerland Site for Peptide Manufacturing Facility

March 05, 2025

The company first announced its intention to build the state-of-the-art facility as part of a €900 million investment in July 2024.

Nelson Labs Launches Rapid Sterility Testing, Cutting Incubation Times

March 04, 2025

The company now performs product-sterility testing through rapid microbiological methods at two laboratory sites in the United States and one in Germany.

Characterization and Qualification of Processes

February 26, 2025

Contract manufacturers have special expertise in the characterization and validation of biopharmaceutical manufacturing processes.

Supplying Sustainably

February 25, 2025

Sponsor companies and contract development and manufacturing companies must ensure that the suppliers they use are following sustainability guidelines to truly produce ‘green’ products.

Working Together to Improve the Environment

February 25, 2025

Contractors are working with sponsor companies to establish and maintain sustainable manufacturing practices in pharma.

Outsourcing Next-Gen Therapies Relies on Expertise and Technology

February 25, 2025

The value of outsourcing partnerships for next-gen biotherapeutics rests in the expertise and technologies that service providers bring to the table.

Savings and Sustainability Sought by Pharma Partners

February 25, 2025

With 2025 now in full swing, this article presents a review of the latest developments in outsourcing services, new facilities, and M&A activity thus far this year.

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 2

February 12, 2025

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, looks at what is involved in developing modern ADCs.

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 1

February 11, 2025

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, discusses the challenges and unmet needs in bringing ADCs to market.